Plasmodium Falciparum Infection

• CLINICAL_TRIALS trial_result · 2026-06-18
  Clinical Trial Results: Pharmacokinetic Study of IV Artesunate to Treat Children With Severe Malaria [Phase 4]

  Phase 4 pharmacokinetic study evaluating intravenous artesunate in children with severe malaria completed, with results posted.

• CLINICAL_TRIALS trial_result · 2025-10-16
  Clinical Trial Update: Anti-malaria MAb in Kenyan Children [Phase 2]

  Phase 2 trial evaluating an anti-malaria monoclonal antibody in Kenyan children has completed and posted results.

• CLINICAL_TRIALS trial_result · 2025-04-02
  Clinical Trial Update: L9LS MAb in Malian Adults [Phase 2]

  Phase 2 trial results for the L9LS monoclonal antibody in Malian adults with malaria have been posted.

• CLINICAL_TRIALS trial_result · 2020-12-02
  Clinical Trial Update: Study to Investigate the Clinical and Parasiticidal Activity and Pharmacokinetics of Different Doses of Artefenomel and Ferroquine in Patients With Uncomplicated Plasmodium Falciparum Malaria [Phase 2]

  Phase 2 trial assessing artefenomel and ferroquine for uncomplicated Plasmodium falciparum malaria with pharmacokinetics and parasiticidal a…

• CLINICAL_TRIALS trial_result · 2020-10-19
  Clinical Trial Update: To Evaluate the Efficacy, Safety, Tolerability and Pharmacokinetics of a Single Dose Regimen of Ferroquine and Artefenomel in Adults and Children With Uncomplicated Plasmodium Falciparum Malaria [Phase 2]

  Phase 2 trial evaluating ferroquine and artefenomel for uncomplicated Plasmodium falciparum malaria was terminated; results posted in 2020.

• Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
• CLINICAL_TRIALS trial_result · 2018-09-20
  Clinical Trial Update: Optimising Operational Use of Artemether-lumefantrine Comparing 3 Day Versus 5 Day [Phase 3]

  A phase 3 trial assessing 3-day versus 5-day regimens of artemether-lumefantrine for Plasmodium falciparum infection has completed.